-+ 0.00%
-+ 0.00%
-+ 0.00%

Mega Genomics Renews Meinian Cooperation Agreement Through 2029

PUBT·11/06/2026 14:24:36
Listen to the news
Mega Genomics Renews Meinian Cooperation Agreement Through 2029
  • Mega Genomics’ board backed renewed cooperation agreements with Meinian OneHealth and Dr. Yu Rong on November 6, 2026.
  • Proposed annual transaction caps for Meinian OneHealth rise from RMB 475 million in 2027 to RMB 628.2 million in 2029.
  • Caps for Yu Rong and his associates increase from RMB 38 million to RMB 50.3 million over the same period.
  • The agreements require independent shareholder approval at an extraordinary general meeting; controlling shareholders and their associates will abstain.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mega Genomics Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261106-12404736), on November 06, 2026, and is solely responsible for the information contained therein.